Literature DB >> 21152996

In-hospital management of heart failure: in 10 years we have improved, but not enough.

Sonia Ferretto1, Chiara Dalla Valle, Sonia Cukon Buttignoni, Luca Brugnaro, Giovanni Maria Boffa.   

Abstract

It is well recognized that the majority of patients with heart failure (HF) are admitted to General Medicine Departments (GMDs), and that the recommendations of the international guidelines for the treatment of HF are often incorrectly applied in hospital practice. We evaluated the treatment of patients with HF discharged from a single hospital over a period of 10 years. The study population comprised two series of patients who were discharged from six GMDs of a single hospital with the diagnosis of HF in the first 2 months of 1998 and 2008. The patients were also divided in two groups on the basis of the type of HF, systolic or diastolic. In 10 years, the number of patients who were discharged with the diagnosis of HF increased, the median age rose from 79 to 82 years and diastolic has become the more common type of HF. The prevalence of comorbidities rose significantly. There was an increased use of ACE-inhibitors and betablockers, and a reduction of digoxin and nitrates. The mortality decreased from 16.7% in 1998 to 9.6% in 2008 (p < 0.02) and hospitalizations became shorter (p < 0.05) considering patients with systolic HF (EF ≤ 45%) the median age rose from 74 to 79 years old (p < 0.01). We recorded an increasing use of betablockers, a reduction in the prescription of digoxin. The percentage of Diastolic HF rose from 55.7% in 1998 to 65.0% in 2008 (p < 0.001). The median age of these patients changed from 79 to 82 years old (p < 0.05). In 10 years, the clinical characteristics and management of HF patients who are hospitalized have changed. Pharmacological treatment has improved, but it still remains far from being adequately compliant with guideline recommendations.

Entities:  

Mesh:

Year:  2010        PMID: 21152996     DOI: 10.1007/s11739-010-0493-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  31 in total

1.  The coming of age of natriuretic peptides: the emperor does have clothes!

Authors:  Alan Maisel
Journal:  J Am Coll Cardiol       Date:  2005-12-13       Impact factor: 24.094

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

3.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Arch Intern Med       Date:  1999-01-11

4.  Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.

Authors:  J E Udelson; C A DeAbate; M Berk; G Neuberg; M Packer; N K Vijay; J Gorwitt; W B Smith; M L Kukin; T LeJemtel; T B Levine; M A Konstam
Journal:  Am Heart J       Date:  2000-03       Impact factor: 4.749

5.  [Treatment of heart failure at a hospital in the north-east of Italy].

Authors:  S C Buttignoni; M Crosato; G M Boffa
Journal:  Ann Ital Med Int       Date:  2001 Jan-Mar

6.  Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.

Authors:  K MacIntyre; S Capewell; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

7.  The economic burden of heart failure.

Authors:  J B O'Connell
Journal:  Clin Cardiol       Date:  2000-03       Impact factor: 2.882

8.  Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

Authors:  Giovanni Pulignano; Donatella Del Sindaco; Luigi Tavazzi; Donata Lucci; Marco Gorini; Francesco Leggio; Maurizio Porcu; Marino Scherillo; Cristina Opasich; Andrea Di Lenarda; Michele Senni; Aldo Pietro Maggioni
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

9.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

10.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001.

Authors:  H M Blackledge; J Tomlinson; I B Squire
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

View more
  1 in total

1.  Effects of smoking in patients treated with cardiac resynchronization therapy.

Authors:  Laura Perrotta; Brunilda Xhaferi; Marco Chiostri; Paolo Pieragnoli; Giuseppe Ricciardi; Luigi Di Biase; Andrea Natale; Ilaria Ricceri; Mazda Biria; Dhanunjay Lakkireddy; Alessandro Valleggi; Michele Emdin; Federica Michelotti; Giosuè Mascioli; Angela Pandozi; Massimo Santini; Luigi Padeletti
Journal:  Intern Emerg Med       Date:  2012-12-19       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.